[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019 Ragweed Pollen Allergy Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 37 pages | ID: 2FF0A0CD4F6EN
VPAResearch

US$ 1,799.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global clinical trial report- “2019 Ragweed Pollen Allergy Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ragweed Pollen Allergy. It presents in-depth analysis of Ragweed Pollen Allergy clinical trials across markets and companies. The research work is for providing complete understanding into trends in Ragweed Pollen Allergy.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Ragweed Pollen Allergy clinical trials by-
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Ragweed Pollen Allergy

The research work is prepared through extensive and continuous research on Ragweed Pollen Allergy trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Ragweed Pollen Allergy patients are identified
  • The report includes panorama of Ragweed Pollen Allergy clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Ragweed Pollen Allergy clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Ragweed Pollen Allergy Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Ragweed Pollen Allergy Clinical Trials by Region
  2.2.2 Average Enrollment of Ragweed Pollen Allergy Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Ragweed Pollen Allergy Treatment, 2019

3. REGION WISE RAGWEED POLLEN ALLERGY CLINICAL TRIALS

3.1 Asia Pacific Ragweed Pollen Allergy Clinical Trials by Country
3.2 Europe Ragweed Pollen Allergy Clinical Trials by Country
3.3 North America Ragweed Pollen Allergy Clinical Trials by Country
3.4 Middle East and Africa Ragweed Pollen Allergy Clinical Trials by Country
3.5 South and Central America Ragweed Pollen Allergy Clinical Trials by Country

4. RAGWEED POLLEN ALLERGY CLINICAL TRIAL TRENDS

4.1 Start Year wise Ragweed Pollen Allergy Clinical Trials
4.2 Phase wise Ragweed Pollen Allergy Clinical Trials
4.3 Trial Status wise Ragweed Pollen Allergy Clinical Trials
4.4 Trial Type wise Ragweed Pollen Allergy Clinical Trials

5. RAGWEED POLLEN ALLERGY AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Ragweed Pollen Allergy Trials by Year
5.2 Average Enrollment in Ragweed Pollen Allergy Trials by Phase
5.3 Average Enrollment in Ragweed Pollen Allergy Trials by Status
5.4 Average Enrollment in Ragweed Pollen Allergy Trials by Type of Trial

6. COMPANIES PARTICIPATING IN RAGWEED POLLEN ALLERGY CLINICAL TRIALS

6.1 Ragweed Pollen Allergy Trials by Sponsor Type
6.2 Ragweed Pollen Allergy Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Ragweed Pollen Allergy Trials- Phase
7.2 Ragweed Pollen Allergy Trials- Phase
7.3 Ragweed Pollen Allergy Trials- Phase
7.4 Ragweed Pollen Allergy Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

LIST OF FIGURES

Figure 1: Ragweed Pollen Allergy Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Figure 7: North America – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Figure 9: Ragweed Pollen Allergy Clinical Trials by Phase
Figure 10: Ragweed Pollen Allergy Clinical Trials by Trial Status
Figure 11: Ragweed Pollen Allergy Clinical Trials by Type
Figure 12: Ragweed Pollen Allergy Clinical Trials by Sponsor Type
Figure 13: Ragweed Pollen Allergy Clinical Trials by Leading Sponsors
Figure 14: Ragweed Pollen Allergy Average Enrollment by Phase
Figure 15: Ragweed Pollen Allergy Average Enrollment by Trial Status
Figure 16: Ragweed Pollen Allergy Average Enrollment by Type
Figure 17: Ragweed Pollen Allergy- Average Enrolment by Type of Sponsors
Figure 18: Ragweed Pollen Allergy- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

LIST OF TABLES

Table 1: Ragweed Pollen Allergy Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Table 5: Europe – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Table 7: North America – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ragweed Pollen Allergy Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Ragweed Pollen Allergy Average Enrollment by Phase
Table 15: Ragweed Pollen Allergy Average Enrollment by Trial Status
Table 16: Ragweed Pollen Allergy Average Enrollment by Type
Table 17: Ragweed Pollen Allergy- Average Enrolment by Type of Sponsors
Table 18: Ragweed Pollen Allergy- Enrolment by Leading Sponsors


More Publications